^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Lung Non-Small Cell Squamous Cancer |
| Drug: | Cyramza (ramucirumab) (VEGFR-2 inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Squamous cell carcinoma (PS 0-2)...Other recommended (no previous IO or previous IO)...Ramucirumab/docetaxel
Secondary therapy:
docetaxel
